Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 21, 2026; 32(39): 120167
Published online Oct 21, 2026. doi: 10.3748/wjg.120167
Published online Oct 21, 2026. doi: 10.3748/wjg.120167
Table 1 Baseline and perioperative characteristics, median (interquartile range)/n (%)
| Variables | Total (n = 1054) | Non-PONV (n = 250) | PONV (n = 804) |
| Sex | |||
| Male | 325 (30.8) | 112 (44.8) | 213 (26.5) |
| Female | 729 (69.2) | 138 (55.2) | 591 (73.5) |
| Age (years) | 32 (26-38) | 33 (27-38) | 32 (26-37) |
| Height (cm) | 165.0 (160.5-172.0) | 168.0 (162.0-175.0) | 165.0 (160.0-170.0) |
| Weight (kg) | 107.0 (93.1-126.7) | 113.0 (98.0-131.8) | 105.0 (92.2-123.9) |
| BMI (kg/m2) | 39.0 (34.8-44.1) | 39.6 (35.7-44.3) | 38.7 (34.5-44.1) |
| ASA grade | |||
| II | 591 (56.1) | 131 (52.4) | 460 (57.2) |
| III | 463 (43.9) | 119 (47.6) | 344 (42.8) |
| Smoking history | 330 (31.3) | 109 (43.6) | 221 (27.5) |
| PONV history | 474 (45.0) | 89 (35.6) | 385 (47.9) |
| Motion sickness history | 424 (40.2) | 77 (30.8) | 347 (43.2) |
| Apfel score | |||
| 0 | 17 (1.6) | 8 (3.2) | 9 (1.1) |
| 1 | 176 (16.7) | 71 (28.4) | 105 (13.1) |
| 2 | 209 (19.8) | 57 (22.8) | 152 (18.9) |
| 3 | 324 (30.7) | 61 (24.4) | 263 (32.7) |
| 4 | 328 (31.1) | 53 (21.2) | 275 (34.2) |
| Hypertension | 231 (21.9) | 71 (28.4) | 160 (19.9) |
| Diabetes | 237 (22.5) | 56 (22.4) | 181 (22.5) |
| Types of antiemetics | |||
| 1 | 17 (1.6) | 5 (2.0) | 12 (1.5) |
| 2 | 385 (36.5) | 66 (26.4) | 319 (39.7) |
| 3 | 245 (23.2) | 55 (22.0) | 190 (23.6) |
| 4 | 407 (38.6) | 124 (49.6) | 283 (35.2) |
| Fluid administration (mL) | 1000 (1000-1200) | 1000 (1000-1200) | 1000 (1000-1200) |
| Duration of anesthesia (minutes) | 133 (115-156) | 130 (110-152) | 135 (115-160) |
| Sufentanil consumption (μg) | 40 (30-45) | 40 (35-45) | 40 (30-45) |
| Remifentanil consumption (μg) | 821 (615-1004) | 851 (649-1068) | 810 (606-998) |
| Dexmedetomidine | 630 (59.8) | 181 (72.4) | 449 (55.8) |
| Preoperative INVR score | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) |
| Preoperative QoR-15 score | 146 (141-150) | 148 (142-150) | 146 (141-150) |
Table 2 Postoperative recovery outcomes, median (interquartile range)/n (%)
| Outcomes | Non-PONV (n = 250) | PONV (n = 804) |
| Time to first flatus (hours) | 21 (14-28) | 22 (16-28) |
| Postoperative hospital stays (days) | 3 (3-4) | 3 (3-4) |
| Postoperative 24 hours QoR-15 score | 131 (123-136) | 122 (112-131) |
| Postoperative 48 hours QoR-15 score | 139 (134-145) | 136 (129-141) |
| Postoperative complications | 2 (0.8) | 6 (0.7) |
- Citation: Yang GY, Zhang XF, Zhao X, Qu H, Zhou P, Wang Y, Tu SM, Xia ZY, Chu QJ. Postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: A prospective cohort study. World J Gastroenterol 2026; 32(39): 120167
- URL: https://www.wjgnet.com/1007-9327/full/v32/i39/120167.htm
- DOI: https://dx.doi.org/10.3748/wjg.120167